Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation



Rating:

Share or cite this content

Citations should be made in the following way:
K. Harris, L. Morra, A. Shah, G. Smaldone (Stony Brook, NY, United States Of America). In vitro effects of vibrating mesh nebulization and radiopharmaceuticals on interferon gamma. Eur Respir J 2007; 30: Suppl. 51, 782

Member's Comments

No comment yet.

Related content which might interest you: Delivery and efficacy of synthetic oligonucleotide vectors to an ARDS model by vibrating mesh nebulisation Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Effect of breath-actuated mechanism on the emitted particle characteristics and lung deposition of a fixed combination drug Source: International Congress 2017 – Inhalers and their use Year: 2017 Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use Source: International Congress 2017 – Inhalers and their use Year: 2017 Aerosol characterization of alpha-1 antitrypsin after nebulization with eFlow®, a novel vibrating membrane nebulizer Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006 A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation. Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Effect of device and formulation on delivery of budesonide suspensions by nebulizers Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002 Visualising biodistribution and biokinetics of inhaled biologicals: application of light sheet imaging technology Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier Year: 2021 Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008 Comparative lung bioavailability of fluticasone/salmeterol via breath actuated vortex spacer and conventional plastic spacers Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010 A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005 In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014 The in vitro fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices Source: Eur Respir J 2005; 26: Suppl. 49, 504s Year: 2005 Inhaled corticosteroid fine particle dose from valved holding chambers Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC) Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Effects of anti-IL-5 receptor alpha in an ex vivo 3D model of COPD Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 In vitro testing of inhalation devices with face masks Source: Eur Respir J 2001; 18: Suppl. 33, 494s Year: 2001 A portable device capable to deliver to the airways filtered air with a submicrometric particle removal efficiency up to 90% Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease Year: 2010 Validation of monodisperse corticosteroid aerosols for in-vivo delivery Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008